GEORGE YANCOPOULOS - 23 Mar 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/** George D. Yancopoulos
Issuer symbol
REGN
Transactions as of
23 Mar 2023
Net transactions value
-$2,940,374
Form type
4
Filing time
27 Mar 2023, 16:41:56 UTC
Previous filing
08 Feb 2023
Next filing
13 Dec 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $203,350 -254 -0.13% $800.59 200,250 23 Mar 2023 By Trust for Chldn. F1, F2, F3
transaction REGN Common Stock Sale $97,742 -122 -0.06% $801.16 200,128 23 Mar 2023 By Trust for Chldn. F1, F3, F4
transaction REGN Common Stock Sale $992,742 -1,237 -0.62% $802.54 198,891 23 Mar 2023 By Trust for Chldn. F1, F3, F5
transaction REGN Common Stock Sale $515,719 -642 -0.32% $803.30 198,249 23 Mar 2023 By Trust for Chldn. F1, F3, F6
transaction REGN Common Stock Sale $204,313 -254 -0.13% $804.38 197,995 23 Mar 2023 By Trust for Chldn. F1, F3, F7
transaction REGN Common Stock Sale $37,861 -47 -0.02% $805.55 197,948 23 Mar 2023 By Trust for Chldn. F1, F3
transaction REGN Common Stock Sale $564,529 -700 -0.35% $806.47 197,248 23 Mar 2023 By Trust for Chldn. F1, F3
transaction REGN Common Stock Sale $324,120 -400 -0.2% $810.30 196,848 23 Mar 2023 By Trust for Chldn. F1, F3
holding REGN Common Stock 569,653 23 Mar 2023 Direct
holding REGN Common Stock 5,869 23 Mar 2023 By 401(k) Plan
holding REGN Common Stock 200,000 23 Mar 2023 by 2022 GRAT I
holding REGN Common Stock 250,000 23 Mar 2023 by 2022 GRAT II
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022.
F2 Represents volume-weighted average price of sales of 254 shares of Company stock on March 23, 2023 at prices ranging from $800.52 to $800.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price.
F3 As investment trustee of trusts for the benefit of the reporting person's children.
F4 Represents volume-weighted average price of sales of 122 shares of Company stock on March 23, 2023 at prices ranging from $801.00 to $801.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price.
F5 Represents volume-weighted average price of sales of 1,237 shares of Company stock on March 23, 2023 at prices ranging from $802.00 to $802.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price.
F6 Represents volume-weighted average price of sales of 642 shares of Company stock on March 23, 2023 at prices ranging from $803.01 to $803.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price.
F7 Represents volume-weighted average price of sales of 254 shares of Company stock on March 23, 2023 at prices ranging from $804.00 to $804.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price.